Clinical trials
Completed Fibrosis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2017 | 3 |
| 2019 | 1 |
| 2022 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bambino Gesù Hospital and Research Institute | 3 |
| Gilead Sciences | 3 |
| University of Milan | 3 |
| AbbVie | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Intercept Pharmaceuticals | 2 |
| Prof. Facchinetti Fabio | 2 |
| University of Roma La Sapienza | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 41 |
| Liver Cirrhosis | 7 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Ascites | 5 |
| Carcinoma, Hepatocellular | 5 |
| Hepatitis C | 5 |
| Fatty Liver | 4 |
| Inflammation | 4 |
| Liver Diseases | 4 |
| Obesity | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.